Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | TSHR | P16473 | 4/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | AHR | P35869 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30583082 | 0.79 | ALDH1A1 (0.36) | ALDH1A1TSHRHSD17B10CYP3A4RECQL | |
| SCHEMBL4077910 | 0.79 | ALDH1A1 (0.56) | ALDH1A1TSHRHSD17B10CYP3A4RECQL | |
| SCHEMBL17645475 | 0.70 | ALDH1A1 (0.41) | ALDH1A1TSHRHSD17B10CYP3A4RECQL | |
| SCHEMBL3672267 | 0.68 | ALDH1A1 (0.35) | ALDH1A1TSHRHSD17B10CYP3A4RECQL | |
| SCHEMBL3665515 | 0.68 | BCHE (0.41) | ALDH1A1TSHRHSD17B10CYP3A4RECQL | |
| SCHEMBL23517582 | 0.67 | RAPGEF4 (0.45) | ALDH1A1TSHRHSD17B10CYP3A4RECQL | |
| SCHEMBL8626365 | 0.65 | ALDH1A1 (0.42) | ALDH1A1TSHRHSD17B10CYP3A4RECQL | |
| SCHEMBL501488 | 0.64 | ALDH1A1 (0.39) | ALDH1A1TSHRALOX15 | |
| SCHEMBL3668782 | 0.62 | ACHE (0.39) | ALDH1A1TSHRALOX15HTTAHR | |
| SCHEMBL30013667 | 0.62 | ACHE (0.39) | ALDH1A1TSHRALOX15HTTAHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9935271-B2 | Organic electroluminescent device based on neutral free-radical electroluminescent material | JILIN UNIVERSTIY (CN) | 2018-04-03 | — | — | US | disclosed |
| US-9935271-B2 | Organic electroluminescent device based on neutral free-radical electroluminescent material | JILIN UNIVERSTIY (CN) | 2018-04-03 | — | — | US | disclosed |
| US-9935271-B2 | Organic electroluminescent device based on neutral free-radical electroluminescent material | JILIN UNIVERSTIY (CN) | 2018-04-03 | — | — | US | disclosed |
| US-20160099415-A1 | ORGANIC ELECTROLUMINESCENT DEVICE BASED ON NEUTRAL FREE-RADICAL ELECTROLUMINESCENT MATERIAL | JILIN UNIVERSITY (CN) | 2016-04-07 | — | — | US | disclosed |
| US-20160099415-A1 | ORGANIC ELECTROLUMINESCENT DEVICE BASED ON NEUTRAL FREE-RADICAL ELECTROLUMINESCENT MATERIAL | JILIN UNIVERSITY (CN) | 2016-04-07 | — | — | US | disclosed |
| US-20160099415-A1 | ORGANIC ELECTROLUMINESCENT DEVICE BASED ON NEUTRAL FREE-RADICAL ELECTROLUMINESCENT MATERIAL | JILIN UNIVERSITY (CN) | 2016-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160099415-A1 | ORGANIC ELECTROLUMINESCENT DEVICE BASED ON NEUTRAL FREE-RADICAL ELECTROLUMINESCENT MATERIAL | MT-ND4L, FARS2, GPX4 | ALDH1A1 2101/4885TSHR 993/4885HSD17B10 4136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.